TFDA-2024-0071-V271
Major variation for application TFDA-2024-0071. Major variation: Facility Change for Kcluximab — minor update
Variation Number
TFDA-2024-0071-V271
Type
Major
Application
Change
Status
Submitted
Fee
€79,575
Submitted
—
Approved
—
Description
Major variation: Facility Change for Kcluximab — minor update